Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04784689 · ClinicalTrials.gov registry record
Host Immune Response to Novel RNA COVID-19 Vaccination
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 50
- Enrollment target
NCT04784689: Completed study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT04784689 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04784689 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
To determine the antibody response level in patients with cancer to the COVID-19 vaccination.
Primary Outcome
Antibody response change over time
Interventions
- BIOLOGICAL COVID-19 Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2022-05-18 |
What the finished NCT04784689 record still lists
NCT04784689 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 Vaccine is the first listed.
NCT04784689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04784689 about?
NCT04784689 is a clinical study titled "Host Immune Response to Novel RNA COVID-19 Vaccination". To determine the antibody response level in patients with cancer to the COVID-19 vaccination.
What is the current status of trial NCT04784689?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-02-24. Estimated completion is 2022-05-18.
What interventions are being tested in trial NCT04784689?
The interventions under investigation include: COVID-19 Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT04784689?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI